| |
| |
|
| Insider
Information: |
Coronado Biosciences Inc |
| Relationship: |
10% Owner |
| City: |
Burlington |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
5,643,671 |
|
|
Indirect Shares
|
265,000 |
|
|
| Direct
Value |
$2,913,826 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
5,908,671 |
|
|
| Total
Value |
$2,913,826 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Cb Pharma Acquisition Corp. |
CNLMU |
10% Owner |
|
0 |
2016-05-20 |
265,000 |
Premium* |
|
|
Checkpoint Therapeutics, Inc. |
CKPT |
10% Owner |
2024-03-20 |
2,096,278 |
2017-03-17 |
0 |
Premium* |
|
|
Avenue Therapeutics, Inc. |
ATXI |
10% Owner |
2024-04-16 |
3,547,393 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
16 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ATXI |
Avenue Therapeutics, Inc. |
10% Owner |
– – • |
2024-04-16 |
4 |
A |
$0.00 |
$0 |
D/D |
413,507 |
3,547,393 |
0 |
- |
|
| CKPT |
Checkpoint Therapeutics, ... |
10% Owner |
– – • |
2024-03-20 |
4 |
A |
$0.00 |
$0 |
D/D |
193,905 |
2,096,278 |
0 |
- |
|
| ATXI |
Avenue Therapeutics, Inc. |
10% Owner |
– – • |
2024-01-02 |
4 |
A |
$0.00 |
$0 |
D/D |
2,101,496 |
3,133,886 |
0 |
- |
|
| CKPT |
Checkpoint Therapeutics, ... |
10% Owner |
– – • |
2023-12-29 |
4 |
A |
$0.00 |
$0 |
D/D |
158,134 |
1,902,373 |
0 |
- |
|
| CKPT |
Checkpoint Therapeutics, ... |
10% Owner |
– – • |
2023-09-25 |
4 |
A |
$0.00 |
$0 |
D/D |
80,906 |
1,744,239 |
0 |
- |
|
| ATXI |
Avenue Therapeutics, Inc. |
10% Owner |
• • • |
2023-09-08 |
4 |
B |
$0.72 |
$301,255 |
D/D |
418,410 |
1,032,390 |
2.45 |
- |
|
| CKPT |
Checkpoint Therapeutics, ... |
10% Owner |
– – • |
2023-06-30 |
4 |
A |
$0.00 |
$0 |
D/D |
81,406 |
1,663,333 |
0 |
- |
|
| ATXI |
Avenue Therapeutics, Inc. |
10% Owner |
– – • |
2023-01-03 |
4 |
A |
$0.00 |
$0 |
D/D |
231,316 |
561,561 |
0 |
- |
|
| ATXI |
Avenue Therapeutics, Inc. |
10% Owner |
– – • |
2022-12-31 |
4 |
A |
$0.00 |
$0 |
D/D |
90,909 |
330,245 |
0 |
- |
|
| CKPT |
Checkpoint Therapeutics, ... |
10% Owner |
– – • |
2017-03-17 |
4 |
A |
$0.00 |
$0 |
D/D |
721,699 |
2,702,705 |
0 |
- |
|
| ATXI |
Avenue Therapeutics, Inc. |
10% Owner |
– – • |
2017-03-13 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
3,316,259 |
|
- |
|
| ATXI |
Avenue Therapeutics, Inc. |
10% Owner |
– – • |
2017-03-13 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
250,000 |
|
- |
|
| CKPT |
Checkpoint Therapeutics, ... |
10% Owner |
– – • |
2016-09-08 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
1,981,006 |
|
- |
|
| CNLMU |
Cb Pharma Acquisition Cor... |
Co-Chairman and CEO |
– – • |
2016-05-20 |
4 |
S |
$0.00 |
$0 |
I/I |
(1,020,000) |
265,000 |
0 |
- |
|
| CNLMU |
Cb Pharma Acquisition Cor... |
Co-Chairman and CEO |
– – • |
2015-01-05 |
4 |
D |
$0.00 |
$0 |
I/I |
(100,000) |
1,285,000 |
0 |
- |
|
| CNLMU |
Cb Pharma Acquisition Cor... |
Co-Chairman and CEO10% Owner |
– – • |
2014-12-12 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
1,385,000 |
|
- |
|
16 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
